UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045113
Receipt number R000051537
Scientific Title Neuroimaging of ME/CFS
Date of disclosure of the study information 2021/08/10
Last modified on 2021/11/26 17:07:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Neuroimaging of ME/CFS

Acronym

PET_ME

Scientific Title

Neuroimaging of ME/CFS

Scientific Title:Acronym

PET_ME

Region

Japan


Condition

Condition

ME/CFS and long COVID

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate neuroinflammation of long COVID and ME/CFS using PET imaging

Basic objectives2

Others

Basic objectives -Others

Feasibility of PET imaging

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Distribution and quantification of neuroinflammation evaluated by PET imaging

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

ME/CFS patients meeting Canadian criteria
Long COVID patients with long-lasting brain fog significantly affecting daily/social life

Key exclusion criteria

Malignancy
Pregnancy
Active infection

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name Sato
Last name Yamamura

Organization

National Center of Neurology and Psychiatry

Division name

Institute of neuroscience

Zip code

1878501

Address

Ogawa-higashi, Kodaira, Tokyo, JAPAN

TEL

042-341-2711

Email

yamamura@ncnp.go.jp


Public contact

Name of contact person

1st name Wakiro
Middle name Sato
Last name Sato

Organization

National Institute of Neuroscience, National Center of Neurology and Psychiatry

Division name

Department of immunology

Zip code

187-8502

Address

Ogawahigashi, Kodaira, Tokyo

TEL

0423412711

Homepage URL


Email

satow@ncnp.go.jp


Sponsor or person

Institute

National Center of Neurology and Psychiatry

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NCNP ethics comittee

Address

4-1-1, Ogawahigashi, Kodaira, Tokyo, JAPAN

Tel

0423412711

Email

ml_rinrijimu@ncnp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 05 Month 27 Day

Date of IRB

2021 Year 06 Month 07 Day

Anticipated trial start date

2021 Year 08 Month 10 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

PET imaging with various cognitive assessment


Management information

Registered date

2021 Year 08 Month 10 Day

Last modified on

2021 Year 11 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051537


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name